Saeedi, Ramesh

Portrait photo of Ramesh  Saeedi

Dr.

Saeedi, Ramesh

MD PhD FRCPC

Academic Ranks(s):

Clinical Assistant Professor, UBC , Medical Biochemist, Royal Columbian Hospital

Affiliations(s):

Royal Columbian Hospital

Short Bio
OpenClose
Academic
OpenClose

Academic Background

  • Fellow (Medical Biochemistry), Royal College of Physicians and Surgeons of Canada. 2015
  • Post- doctoral fellowship, BC Center for excellence in HIV/AIDS, University of British Columbia, 2010
  • PhD, University of British Columbia. 2008
  • MD, University of Guilan, Iran. 1997

Awards and Recognition

Publications

  • Saeedi R, Mojebi-Mogharar A, Sandhu SK, Dubland JA, Ford JA, Yousefi M, Pudek M, Holmes DT, Erb SR, Kwan WCP, Kendler DL, Yoshida EM. Effects of treatments with Lamivudine, Entecavir, or Tenofovir on factors involved in phosphate homeostasis and bone turnover markers in patients with chronic hepatitis B virus infection.. (Accepted, Annals of Hepatology)
  • Harris M, Ganase B, Watson B, Hull MW, Guillemi SA, Zhang W, Saeedi R, Harrigan PR. Efficacy and safety of “unboosting” atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF. HIV Clin Trials. 2017;9:1-9.
  • Saeedi R, Frohlich J. Lipoprotein (a), an Independent Cardiovascular Marke.r Invited review  article, Clinical Diabetes and Endocrinology. 2016;2:7
  • Saeedi R, Johns K, Frohlich J, Bennett MT, Bondy G. Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients. Lipids Health Dis. Lipids Health Dis. 2015; 14:57.
  • Saeedi R, Dabirvaziri P; Fouladi Nashta N; Yousefi M; Guillemi S; Montaner J; Frohlich J; Harris M; Bondy G. Effects of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Metabolic Abnormalities and Body Weight in HIV-infected Subjects with or without Type 2 Diabetes. Journal of HIV & AIDS.2015
  • Saeedi R, Jones K, Bennett MT, Bondy G. Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients. Lipids Health Dis. 2015; 14:57
  • Saeedi R, Li M, Frohlich J. A review on lecithin:cholesterol acyltransferase deficiency. Clin Biochem. 2014;48(7-8):742-5.
  • Saeedi R , Li M ,  Rankin S , Frohlich J .Re: Variance in niacin response in individuals with elevated lipoprotein(a): Re: Dramatic lowering of very high Lp(a) in response to niacin. J Clin Lipidol, 2014; 8(6):647
  • Li M, Saeedi R, Rabkin SW, Frohlich J. Dramatic lowering of very high Lp(a) in response to niacin. J Clin Lipidol. 2014 Jul-Aug;8(4):448-50
  • Saeedi R, Li M, Allard M, Frohlich J. Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol. Clin Biochem. 2014 Aug;47(12):1098-9
  • Allard MD, Saeedi R, Yousefi M, Frohlich J. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort. Lipids Health Dis. 2014 Apr 8;13:65
  • Saeedi R, Jiang SY, Holmes DT, Kendler DL. Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia. Calcif Tissue Int. 2014 Jun;94(6):665-8.
  • Johns K, Saeedi R, Mancini GB, Bondy G. Ankle brachial index screening for occult vascular disease is not useful in HIV-positive patients. AIDS Res Hum Retroviruses. 2010 Sep;26(9):955-9.
Research
OpenClose

Research Interest

  • Lipidology
  • Endocrinology
  • Cardiovascular disease

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Clinical chemistry
  • Undergraduate and postgraduate education